p145, a protein with associated tyrosine kinase activity in a human gastric carcinoma cell line
about
Scatter factor and hepatocyte growth factor are indistinguishable ligands for the MET receptorDefective posttranslational processing activates the tyrosine kinase encoded by the MET proto-oncogene (hepatocyte growth factor receptor).Alternative splicing generates isoforms of the met receptor tyrosine kinase which undergo differential processingActivation of HER family members in gastric carcinoma cells mediates resistance to MET inhibition.Monovalency unleashes the full therapeutic potential of the DN-30 anti-Met antibodyIdentification of a novel MET mutation in high-grade glioma resulting in an auto-active intracellular proteinHepatocyte growth factor and Met receptor expression in human pancreatic carcinogenesisTransfer of motogenic and invasive response to scatter factor/hepatocyte growth factor by transfection of human MET protooncogene.Role of vitamin D3 combined to alginates in preventing acid and oxidative injury in cultured gastric epithelial cells.The tyrosine kinase encoded by the MET proto-oncogene is activated by autophosphorylationTumorigenicity of the met proto-oncogene and the gene for hepatocyte growth factorC-terminal truncated forms of Met, the hepatocyte growth factor receptorcMET in NSCLC: Can We Cut off the Head of the Hydra? From the Pathway to the Resistance.Inhibition of ligand-independent constitutive activation of the Met oncogenic receptor by the engineered chemically-modified antibody DN30.Increase of MET gene copy number confers resistance to a monovalent MET antibody and establishes drug dependence.An 'in-cell trial' to assess the efficacy of a monovalent anti-MET antibody as monotherapy and in association with standard cytotoxicsA preclinical algorithm of soluble surrogate biomarkers that correlate with therapeutic inhibition of the MET oncogene in gastric tumors.The hepatocyte growth factor and its receptor.The hepatocyte growth factor receptor kinase-mediated phosphorylation of lipocortin-1 transduces the proliferating signal of the hepatocyte growth factor.Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth.Hepatocyte growth factor/c-met signaling in regulating urokinase plasminogen activator in human stomach cancer: A potential therapeutic target for human stomach cancer.Iron Absorption from Three Commercially Available Supplements in Gastrointestinal Cell Lines.Dual Constant Domain-Fab: A novel strategy to improve half-life and potency of a Met therapeutic antibody.Mutations in the met oncogene unveil a "dual switch" mechanism controlling tyrosine kinase activity.Aberrant elevation of tyrosine-specific phosphorylation in human gastric cancer cells.Soluble c-Met protein as a susceptible biomarker for gastric cancer risk: A nested case-control study within the Korean Multicenter Cancer Cohort.Overexpression of the c-MET/HGF receptor in human thyroid carcinomas derived from the follicular epithelium.Protein tyrosine kinases in human breast cancer: kinetic properties and evidence for the presence of two forms of native enzyme.
P2860
Q24564783-6D69FB77-81A1-4A6D-B256-F0EBC464AFEBQ33238614-59883BAD-B3C3-4D47-9979-A48AA4E92EFBQ33263389-A985F3BE-6FA5-4985-8E93-1F4FAC4BD767Q33942266-F3EB5A09-B325-4652-97CB-E9836802749EQ34285473-4766C7CB-E384-4B39-BCC4-56147E6F8139Q35747784-BB64F9CE-DC8A-422A-A82E-404176C8AA58Q35798481-4B6EA16F-70F1-40EB-B5B3-A487FF64AC76Q36065558-B597EBEB-2BB5-4433-B430-74120DF75231Q36157989-2AE418D8-676B-445A-8D46-948342080F32Q36687206-5C6FA85E-B3C4-4756-811D-C29C1F5A3B95Q36705281-2EBA3376-02CD-45E4-9AEE-0854D0307EA7Q36743037-79DA4748-6ADB-4370-B104-CFF24D29151FQ38393333-EAF61C52-536F-404D-BD4D-178F7078CC8CQ38859217-1399A947-EE35-4E0E-B75E-D5DDE2FC476BQ38976616-D8F266D8-4DBF-45C0-988B-4A33C1CC8665Q39037450-BB70B378-53DD-49F5-81D0-0312D68FCECBQ39557213-5F232AC6-24DE-41BC-8425-E68006B4518CQ40860432-4EA02609-AF9C-4A18-8402-737465364F62Q41155456-B381C5AF-43B6-4B17-88EB-CD473D8514A6Q41596252-4C0307E7-46A3-4D09-A39A-370E0E82A3B6Q41870321-6D36F829-F9E5-4A3D-8DD8-42F855A62D68Q42259609-C7EBAF77-254B-426B-904B-7DEE6017200EQ42282846-49C316DA-57B4-4F8A-9F2A-A7DE00148399Q42801835-42F0865A-CE80-4AFD-BCEA-7D27F503257DQ42808318-3554AC57-984D-493A-B0D4-9DEBA95D9368Q44601949-78F16894-D8E2-4F07-B726-4F407790B8EAQ48075337-03FAC6E2-310D-42A3-A431-F348C22CBA93Q53678570-0AC43D62-FF20-44FA-9408-68A7E3175CA7
P2860
p145, a protein with associated tyrosine kinase activity in a human gastric carcinoma cell line
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
p145, a protein with associate ...... an gastric carcinoma cell line
@ast
p145, a protein with associate ...... an gastric carcinoma cell line
@en
type
label
p145, a protein with associate ...... an gastric carcinoma cell line
@ast
p145, a protein with associate ...... an gastric carcinoma cell line
@en
prefLabel
p145, a protein with associate ...... an gastric carcinoma cell line
@ast
p145, a protein with associate ...... an gastric carcinoma cell line
@en
P2093
P2860
P356
P1476
p145, a protein with associate ...... an gastric carcinoma cell line
@en
P2093
L Chiadò-Piat
P M Comoglio
R Ferracini
P2860
P304
P356
10.1128/MCB.8.8.3510
P407
P577
1988-08-01T00:00:00Z